Dr. Roger Lo Awarded NIH Grant to Tackle Melanoma Treatment Resistance

Dr. Roger Lo at the University of California, Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center was awarded a $2 million grant from the National Institutes of Health to investigate innovative strategies to prevent drug resistance in melanoma treatment and improve the effectiveness of MAPK inhibitors, a common treatment for patients with melanomas that carry the BRAFV600 mutation.